Finance

Lists
ZVSA:OTCMKTS
Zyversa Therapeutics Inc
$0.080
-0.63%
(-0.00050) 1D
Oct 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZVSA...
Open
$0.08
High
$0.10
Low
$0.08
Mkt. cap
643.62K
Avg. vol.
5.78K
Volume
16.81K
52-wk high
$0.30
52-wk low
$0.08
EPS
-$3.32
Beta
0.85
Shares outstanding
8.10M
No. of employees
6
Open
$0.08
High
$0.10
Low
$0.08
Mkt. cap
643.62K
Avg. vol.
5.78K
Volume
16.81K
52-wk high
$0.30
52-wk low
$0.08
EPS
-$3.32
Beta
0.85
Shares outstanding
8.10M
No. of employees
6
News stories
From web sources and news partners
About Zyversa Therapeutics Inc
CEO-
Employees6
Founded2014
HeadquartersWeston, Florida, United States
SectorBiotechnology
Websitezyversa.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
409.94K
365.05K
79.24K
57.62K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.63M
1.74M
472.62K
1.25M
Operating expense
2.04M
2.10M
551.86K
1.30M
Total operating expenses
2.04M
2.10M
551.86K
1.30M
Operating income
-2.04M
-2.10M
-551.86K
-1.30M
Other non operating income
-37.15K
226.26K
-196.31K
-12.17K
EBT including unusual items
-2.21M
-20.66M
-678.57K
-1.79M
EBT excluding unusual items
-2.21M
-2.01M
-880.43K
-1.45M
Income tax expense
-
-851.66K
-
-
Effective tax rate
-
4.12%
-
-
Other operating expenses
-
-
-
-
Net income
-2.21M
-19.81M
-678.57K
-1.79M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-130.04K
-131.35K
-132.26K
-132.51K
Net interest expenses
-130.04K
-131.35K
-132.26K
-132.51K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.04M
-2.10M
-550.12K
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps